BRIEF published on 04/14/2026 at 17:50, 2 months 12 days ago IMPLANET Reports 18% Revenue Growth in Q1 2026 Revenue Growth Financial Strategy United States Medical Equipment IMPLANET
BRIEF published on 04/14/2026 at 17:50, 2 months 12 days ago IMPLANET annonce une croissance de son chiffre d'affaires de 18 % au premier trimestre 2026 Stratégie Financière États-Unis Croissance Des Revenus Équipement Médical IMPLANETTE
PRESS RELEASE published on 04/14/2026 at 17:45, 2 months 12 days ago Inside Information / Other news releases IMPLANET reports Q1 2026 revenue of €3.03 million, up 18%, driven by strong growth in the United States and medical equipment distribution, particularly the ultrasonic scalpel (SMTP) Revenue United States Medical Equipment IMPLANET Q1 2026
BRIEF published on 04/14/2025 at 18:46, 1 year 2 months ago Compte rendu de l’Assemblée Générale Mixte d'IMPLANET Chiffre D’affaires Assemblée Générale Mandats Renouvelés Résolutions Adoptées IMPLANET
BRIEF published on 04/14/2025 at 18:46, 1 year 2 months ago Minutes of the IMPLANET Combined General Meeting Turnover General Assembly Mandates Renewed Resolutions Adopted IMPLANET
PRESS RELEASE published on 04/14/2025 at 18:41, 1 year 2 months ago Informations privilégiées / Autres communiqués Implanet tient son Assemblée Générale Mixte avec succès. Résolutions adoptées incluant ratification de cooptation et renouvellement de mandats. Prochain communiqué financier le 8 juillet 2025 Resolutions Assemblée Générale Mixte Communiqué Financier Cooptation IMPLANET
BRIEF published on 10/08/2024 at 18:51, 1 year 8 months ago IMPLANET : Croissance de 50% du chiffre d'affaires au troisième trimestre 2024 Chiffre D'affaires Croissance Marché Américain Technologies Médicales Équipements Médicaux
BRIEF published on 10/08/2024 at 18:51, 1 year 8 months ago IMPLANET: 50% growth in turnover in the third quarter of 2024 Growth American Market Turnover Medical Equipment Medical Technologies
PRESS RELEASE published on 10/08/2024 at 18:46, 1 year 8 months ago Informations privilégiées / Autres communiqués Implanet annonce un chiffre d'affaires en forte croissance au troisième trimestre 2024, soutenu par des activités en France et aux USA, avec un focus sur la chirurgie orthopédique Chiffre D'affaires Croissance France USA IMPLANET
PRESS RELEASE published on 10/08/2024 at 18:46, 1 year 8 months ago Inside Information / Other news releases IMPLANET announces €2.3 million Q3 revenue with 50% growth and €6.4 million for 9 months 2024. Exclusive partnership success with elliquence. Company aims for strategic growth in spine surgery market Revenue Growth Exclusive Partnership Spine Surgery IMPLANET
Published on 06/27/2026 at 01:40, 6 hours 53 minutes ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 8 hours 33 minutes ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 9 hours 33 minutes ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 9 hours 43 minutes ago Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/26/2026 at 22:15, 10 hours 18 minutes ago Revive Therapeutics Announces Proposed Private Placement
Published on 06/27/2026 at 00:05, 8 hours 28 minutes ago EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 8 hours 29 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 8 hours 57 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 8 hours 57 minutes ago EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 9 hours 6 minutes ago EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
Published on 06/26/2026 at 17:45, 14 hours 48 minutes ago Descriptif du programme de rachat d'actions
